Gatekeeper. Subject to the provisions of Section 2.7(b), the inquiries and responses made by one Party to the other in connection with Section 2.4(a) shall be made in writing to the attention of a designated employee of Alnylam mutually agreeable to both Parties (the “Gatekeeper”) who will be bound by confidentiality obligations to both Parties. Each Party agrees to provide the Gatekeeper with full and complete copies of all records and information (including un-redacted copies of the relevant Third Party agreements) that are necessary for the Gatekeeper to render his or her determination.
Gatekeeper. The inquiries and responses made by one Party to the other in connection with Sections 2.1 and 3.1(e)(ii) through (iii) shall be made in writing to the attention of an independent attorney registered to practice before the United States Patent and Trademark Office mutually agreeable to both Parties (the "Gatekeeper") who will be bound by confidentiality obligations to both Parties. The Gatekeeper's responsibility shall be to ensure that each Party complies on an ongoing basis with the terms and conditions of Sections 2.1 and 3.1(e)(ii) through (iii). Each Party agrees to provide the Gatekeeper with full and complete copies of all records and information (including un-redacted copies of the relevant Third Party agreements) that are necessary for the Gatekeeper to render its determination. In the event that the Gatekeeper determines that, in connection with an inquiry or response made by either Party in connection with Sections 2.1 or 3.1(e)(ii) through (iii), such Party may not have complied with the provisions of one or more of those Sections, the Gatekeeper shall issue a written report to both Parties stating with specificity such actual or suspected non-compliance, and each Party hereby consents to the disclosure to the other Party of any confidential information included in such report (provided that such information shall be treated by the Parties' as Confidential Information pursuant to Article V). The Parties shall share equally the fees, costs and expenses of the Gatekeeper's appointment.
Gatekeeper. The Parties will agree on an independent attorney nominated by Ablynx and reasonably acceptable to Sanofi to act as an information “gatekeeper” (the “Gatekeeper”) through which Sanofi may inquire (which inquiry may be done via email or an internationally recognized overnight courier) as to whether any Single Target or Target Combination that Sanofi intends to designate as a Sanofi Target (whether pursuant to Section 2.4.1 or 2.4.2) is a Blocked Target (an “Inquiry”), provided that, if the Gatekeeper informs Sanofi in response to an Inquiry that the subject Single Target or Target Combination is a Blocked Target, such Inquiry will not be deemed an Inquiry for purposes of applying those limitations set forth in Section 2.5.5. [...***...]. Ablynx will cause the Gatekeeper to enter into a customary confidentiality agreement that includes confidentiality obligations at least as stringent as the provisions set forth in Article VI and prohibits the Gatekeeper from disclosing the identity CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[...***...]”. AN UNREDACTED VERSION OF THE DOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. of a Target that was the subject of any Inquiry. Nothing in this Section 2.5 will preclude Sanofi from contacting Ablynx directly regarding the availability of Targets or otherwise, to which Ablynx will respond in its discretion, and any such direct contact of Ablynx will not constitute an Inquiry hereunder. The initial Gatekeeper will be [...***...].
Gatekeeper. Within [***] days after the Effective Date, Caribou shall engage an independent Third Party mutually agreeable to the Parties (the “Gatekeeper”) for the purposes of performing the applicable functions set forth in Sections 3.2.4, 3.2.5, and 3.2.6, including (a) maintaining, in accordance with Section 3.2.4, a list of Targets that are not available for nomination by AbbVie under this Agreement (“Unavailable Targets”) and (b) confirming whether Proposed Targets and Nominated Targets are on the list of Unavailable Targets. [***] Such engagement shall be on terms consistent with this Agreement and mutually agreeable to the Parties, including provisions relating to confidentiality. The identity of the Unavailable Targets is deemed to be the Confidential Information of Caribou and the identity of the Reserved Targets, Proposed Targets, and Nominated Targets is deemed to be the Confidential Information of AbbVie.
Gatekeeper. Credits incurred and paid to a FCM acting as Gatekeeper shall be shared equally between the Union and the Company. A maximum of two (2) days shall be allocated to the Gatekeeper each calendar month. Such days shall be credited at minimum daily credit. Such credits shall appear on the FCMs monthly schedule as "GKPR". Additional credits may be allocated if mutually agreed upon by the Company and the Gatekeeper. It is the Gatekeeper's responsibility to advise Crew Planning of the requested days allocated for the purpose of his duties. FDM meetings shall occur on dates that are mutually agreed upon by the Safety Department and the Gatekeeper. Accrued credits allocated to the Gatekeeper shall be reconciled at the end of each calendar year for the purpose of sharing the expense equally between the Company and the Union. If for any reason the Gatekeeper must dedicate time exceeding two (2) days in a calendar month, he shall be credited at minimum daily credit for each additional day or portion thereof. If the Sunwing fleet expands beyond thirty (30) aircraft during the winter season, the Union and Company will discuss additional credit requirements for gatekeeping purposes. In the event the work load increases to a level that the current Gatekeeper requires assistants, the Union and Company will discuss the requirements for an additional Gatekeeper/keepers to assist in the duties.
Gatekeeper. The Gatekeeper (GK) is an H.323 entity on the Internet that provides address translation and controls access to the network for H.323 Terminals and Gateways. The Gatekeeper may also provide other services to the H.323 terminals and Gateways, such as bandwidth management and locating Gateways. Gateway: An H.323 Gateway (GW) is an endpoint on the Internet which provides for real-time, two-way communications between H.323 Terminals on the Network and other ITU Terminals on a wide area network, or to VoIP Clients. Other ITU Terminals include those complying with Recommendations H.310 (H.320 on B-ISDN), H.320 (ISDN), H.321 (ATM), H.322 (GQOS-LAN), H.324 (GSTN), H.324M (Mobile), and V.70 (DSVD).
Gatekeeper. The Gatekeeper, which is optional in an H.323 system, provides limited call control services to H.323 Entities, including the following primary services: • Address Translation • Admissions Control • Bandwidth Control In order to provide CMAC-less H.323 clients (client = terminal or gateway) with the basic needed call information, CMA compliant H.323 Gatekeepers will be needed. A CMA compliant H.323 Gatekeeper will have an H.323 Gatekeeper interface to interact with H.323 clients, and a CMAC to interact with CMAS’s. It will basically translate H.323 RAS protocol requests to/from CMAP requests, allowing seamless integration of pure H.323 clients with the CMA system. The level of functionality which pure H.323 clients will receive from the CMA system is obviously limited to the H.323 Gatekeeper access protocol’s syntax and semantics.
Gatekeeper. Principal Date Approved TEI: September 2018 Date of Next Review April 2021 Date Effective: September 2018 Date Approved Durham: N/A Supercedes: Placement Policy v.2 (2018-19)
Gatekeeper. Medical detoxification Participants will be given priority for these beds. Participants who 37 have received social model detoxification services at a county-contracted facility may also be 1 considered. In the eventuality no qualified medical or social model detoxification Participants are 3 ADAS Gatekeeper. CONTRACTOR shall reserve two (2) designated beds at the facility. Designated 4 bed Participants will receive the same services as set forth under Subparagraph VI.E. of this Exhibit A 5 to the Agreement throughout the Agreement.
Gatekeeper. Medical detoxification Participants will be given priority for these beds. Participants who 4 have received social model detoxification services at a county-contracted facility may also be 5 considered. In the eventuality no qualified medical or social model detoxification Participants are 6 available for immediate placement, CONTRACTOR shall accept an alternate Participant from 7 C ONTRACTOR’s waitlist if approved by ADASADMINISTRATOR Gatekeeper. CONTRACTOR 8 shall reserve two (2) coordinate with COUNTY to determine the number of designated beds at the 9 facility. for Participants transferring from a detox service provider. Designated bed Participants are not 10 required to follow the admission criteria established below. Designated bed Participants will receive the 11 same services as set forth under Subparagraph VI.EI.C.1. of this Exhibit AD to the Agreement.
